Gwrthrychau elusennol
(1) THE RELIEF OF SICKNESS AND THE PRESERVATION OF HEALTH OF PEOPLE WITH HUGHES (ANTIPHOSPHOLIPID) SYNDROME (“HUGHES SYNDROME”) IN PARTICULAR THOUGH THE PROVISION OF INFORMATION, SUPPORT AND PRACTICAL ADVICE TO PATIENTS THEIR FAMILIES AND CARERS;
(2) TO ADVANCE THE EDUCATION OF THE GENERAL PUBLIC IN ALL AREAS RELATING TO HUGHES SYNDROME; AND
(3) TO PROMOTE AND CARRY OUT FOR THE PUBLIC BENEFIT RESEARCH IN HUGHES SYNDROME AND TO PUBLISH OR OTHERWISE DISSEMINATE THE USEFUL RESULTS OF SUCH RESEARCH.
